This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Social Bookmarking   What's this?

Problems and Possible Improvements

Jay S. Cohen, MD; Paul A. Insel, MD

Arch Intern Med. 1996;156(13):1375-1380.

Abstract
The Physicians' Desk Reference (PDR) is a widely used source of drug information by American physicians and patients, but as we shall discuss, it suffers from numerous shortcomings.¹ The PDR is a collection of written and pictorial information that is provided and paid for by pharmaceutical manufacturers. The written material for a given drug is a compilation of data and recommendations that are identical to those in the drug's package insert. The wording and directives that are included in these package inserts (and thus in the PDR) represent information that the pharmaceutical companies are permitted to present following discussion and approval by the Food and Drug Administration (FDA), Rockville, Md. The PDR is thus a negotiated effort of commercial enterprises and governmental regulators.

Author Affiliations
From the Departments of Psychiatry (Dr Cohen) and Pharmacology and Medicine (Dr Insel), University of California, San Diego, School of Medicine, La Jolla.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Pharmaceutical Manufacturer Sponsorship and Drug Information
Ethan M. Basch, Mark F. Bonfiglio, and Jay S. Cohen
Arch Intern Med. 2001;161(21):2625-2626.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Why Aren't Lower, Effective, OTC Doses Available Earlier by Prescription?
Cohen
The Annals of Pharmacotherapy 2003;37:136-142.
ABSTRACT | FULL TEXT  

Timing of New Black Box Warnings and Withdrawals for Prescription Medications
Lasser et al.
JAMA 2002;287:2215-2220.
ABSTRACT | FULL TEXT  

Pharmaceutical Manufacturer Sponsorship and Drug Information
Basch et al.
Arch Intern Med 2001;161:2625-2626.
FULL TEXT  

Dose Discrepancies Between the Physicians' Desk Reference and the Medical Literature, and Their Possible Role in the High Incidence of Dose-Related Adverse Drug Events
Cohen
Arch Intern Med 2001;161:957-964.
ABSTRACT | FULL TEXT  

Adverse Drug Effects, Compliance, and Initial Doses of Antihypertensive Drugs Recommended by the Joint National Committee vs the Physicians' Desk Reference
Cohen
Arch Intern Med 2001;161:880-885.
ABSTRACT | FULL TEXT  

The PDR: Another View
Jones
Arch Intern Med 1997;157:576-576.
ABSTRACT  

The American Hospital Formulary Service Information Books Beat the PDR
Hooper
Arch Intern Med 1997;157:575-576.
ABSTRACT  

The PDR Is Food and Drug Administation-Approved Labeling
Oddis
Arch Intern Med 1997;157:576-579.
ABSTRACT